Literature DB >> 22569978

Splenectomy and gastric vein ligature in hepatosplenic schistosomiais: effects upon esophageal variceal pressure and endoscopic risk factors of esophageal variceal bleeding.

João Evangelista-Neto1, Fernanda Fernandez Pereira, Suênia Tavares França, Fernando José Amaral, Carlos Teixeira Brandt, Olival Cirilo Lucena da Fonseca-Neto, Cláudio Moura Lacerda.   

Abstract

BACKGROUND: A significant number of patients with schistosomiasis develop the hepatosplenic form, with portal hypertension, in which bleeding caused by rupture of esophagogastric varices emerged as the leading cause of morbidity and mortality. AIM: To investigate the effects of splenectomy and ligature of the left gastric vein on risk factors for bleeding of esophagogastric varices in patients with schistosomiasis mansoni, hepatosplenic form, with a history of upper gastrointestinal bleeding.
METHODS: The main risk factors of bleeding from esophagogastric varices were studied in 34 patients. The following parameters were investigated: 1) esophageal variceal pressure, measured by the endoscopic pneumatic balloon technique; 2) size, fundamental color, extension and red signs of esophageal varices, gastric varices and gastropathy of portal hypertension. The evaluations were performed in the preoperative period, immediate postoperative period (between the sixth and eighth postoperative days) and the sixth month of follow-up.
RESULTS: The variceal pressure has fallen from 22.3+/-2.6 mmHg before surgery to 16.0+/-3.0 mmHg in the immediate postoperative period (p<0.001), reaching 13.3+/- 2.6 mmHg in the sixth month of follow-up. A significant reduction of the frequency of the parameters associated with a greater risk of hemorrhage was observed between the preoperative period and six-month follow-up, when the proportion of large esophageal varices (p<0.05), varices extending to the upper esophagus (p<0.05), bluish varices (p<0.01), varices with red signs (p<0.01) and gastropathy (p<0.05) decreased.
CONCLUSION: In patients with hepatosplenic schistosomiasis with a previous history of variceal hemorrhage, splenectomy and gastric vein ligation was effective in reducing the main hemorrhagic risk factors until the sixth month of follow-up, indicating a good way to control the bleeding episodes.

Entities:  

Mesh:

Year:  2012        PMID: 22569978     DOI: 10.1590/s0102-67202012000100010

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  4 in total

1.  Splenectomy Combined with Endoscopic Variceal Ligation (EVL) versus EVL Alone for Secondary Prophylaxis of Variceal Bleeding in Hepatosplenic Schistosomiasis: A Retrospective Case-Control Study.

Authors:  Jolivet Auguste Rakotomalala; Chantelli Iamblaudiot Razafindrazoto; Nitah Harivony Randriamifidy; Behoavy Mahafaly Ralaizanaka; Sonny Maherison; Domoina Harivonjy Hasina Laingonirina; Mialitiana Rakotomaharo; Anjaramalala Sitraka Rasolonjatovo; Mamisoa Anicet Rakotovao; Andry Lalaina Rinà Rakotozafindrabe; Tovo Harimanana Rabenjanahary; Rija Fanantenantsoa; Soloniaina Hélio Razafimahefa; Rado Manitrala Ramanampamonjy
Journal:  Hepat Med       Date:  2022-05-18

2.  Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.

Authors:  Chikwendu J Ede; Dimitrinka Nikolova; Martin Brand
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03

Review 3.  Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature.

Authors:  Francesca Tamarozzi; Veronica A Fittipaldo; Hans Martin Orth; Joachim Richter; Dora Buonfrate; Niccolò Riccardi; Federico G Gobbi
Journal:  PLoS Negl Trop Dis       Date:  2021-03-25

4.  Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review.

Authors:  Karla Sawada Toda; Luciana Kikuchi; Aline Lopes Chagas; Ryan Yukimatsu Tanigawa; Denise Cerqueira Paranaguá-Vezozzo; Túlio Pfiffer; Manoel de Souza Rocha; Venâncio Avancini Ferreira Alves; Flair José Carrilho
Journal:  J Clin Transl Hepatol       Date:  2015-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.